Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Activate Immunotherapy

Activate Immunotherapy?uq=UG6efJS6
1997 FOUNDED
OOB STATUS
11-20 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Operator of a clinical-stage immuno-oncology platform designed to treat solid tumors. The company's platform utilizes a novel approach for activating the body's immune system to recognize and destroy cancer cells, enabling physicians to treat cancer in their patients effectively.

Formerly Known As
NovaRx
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 8395 Camino Santa Fe Drive
  • Suite A
  • San Diego, CA 92121
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Activate Immunotherapy’s full profile, request a free trial.

Activate Immunotherapy Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 000.00 Completed Out of Business
9. Later Stage VC 15-Aug-2016 000.00 Completed Generating Revenue
8. Merger/Acquisition 02-May-2016 Cancelled Generating Revenue
7. Later Stage VC (Series C) 01-Sep-2014 0000 000.00 Completed Generating Revenue
6. Later Stage VC (Series D) 14-Mar-2007 0000 000.00 Completed Generating Revenue
5. Grant 01-Jan-2007 00.000 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 26-Aug-2005 000.00 000.00 Completed Generating Revenue
3. Grant 12-May-2004 00.000 Completed Generating Revenue
2. Grant 01-Jan-2003 $2.63M Completed Generating Revenue
1. Grant 09-Sep-2002 $2.95M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Activate Immunotherapy Executive Team (12)

Name Title Board
Seat
Contact
Info
Justin Murdock Chief Executive Officer & Executive Chairman
Todd Binder Chief Operating Officer
Habib Fakhrai Ph.D Co-Founder & Chief Scientific Officer
Feridoun Karimi-Busheri Ph.D Senior Investigator and Director of Stem Cell Department
Emmet O'Neal III Co-Founder

3 Former Executives

You’re viewing 5 of 12 executives. Get the full list »

Activate Immunotherapy Board Members (1)

Name Representing Role Since Contact
Info
Justin Murdock Activate Immunotherapy Chief Executive Officer & Executive Chairman 000 0000